node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AGXT | AGXT2 | ENSP00000302620 | ENSP00000231420 | alanine-glyoxylate aminotransferase | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | 0.988 |
AGXT | ALAS2 | ENSP00000302620 | ENSP00000332369 | alanine-glyoxylate aminotransferase | aminolevulinate, delta-, synthase 2 | 0.906 |
AGXT | GATM | ENSP00000302620 | ENSP00000379895 | alanine-glyoxylate aminotransferase | glycine amidinotransferase (L-arginine-glycine amidinotransferase); Catalyzes the biosynthesis of guanidinoacetate, the immediate precursor of creatine. Creatine plays a vital role in energy metabolism in muscle tissues. May play a role in embryonic and central nervous system development. May be involved in the response to heart failure by elevating local creatine synthesis | 0.918 |
AGXT | GCAT | ENSP00000302620 | ENSP00000371110 | alanine-glyoxylate aminotransferase | glycine C-acetyltransferase | 0.903 |
AGXT | GLDC | ENSP00000302620 | ENSP00000370737 | alanine-glyoxylate aminotransferase | glycine dehydrogenase (decarboxylating); The glycine cleavage system catalyzes the degradation of glycine. The P protein binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein | 0.965 |
AGXT | GNMT | ENSP00000302620 | ENSP00000361894 | alanine-glyoxylate aminotransferase | glycine N-methyltransferase; Catalyzes the methylation of glycine by using S- adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy). Possible crucial role in the regulation of tissue concentration of AdoMet and of metabolism of methionine | 0.910 |
AGXT | PIPOX | ENSP00000302620 | ENSP00000317721 | alanine-glyoxylate aminotransferase | pipecolic acid oxidase; Metabolizes sarcosine, L-pipecolic acid and L-proline | 0.907 |
AGXT | SARDH | ENSP00000302620 | ENSP00000360938 | alanine-glyoxylate aminotransferase | sarcosine dehydrogenase | 0.929 |
AGXT | SHMT1 | ENSP00000302620 | ENSP00000318868 | alanine-glyoxylate aminotransferase | serine hydroxymethyltransferase 1 (soluble); Interconversion of serine and glycine (By similarity) | 0.963 |
AGXT | SHMT2 | ENSP00000302620 | ENSP00000333667 | alanine-glyoxylate aminotransferase | serine hydroxymethyltransferase 2 (mitochondrial); Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Interconversion of serine and glycine. Associates with mitochondrial DNA | 0.961 |
AGXT2 | AGXT | ENSP00000231420 | ENSP00000302620 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | alanine-glyoxylate aminotransferase | 0.988 |
AGXT2 | ALAS2 | ENSP00000231420 | ENSP00000332369 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | aminolevulinate, delta-, synthase 2 | 0.905 |
AGXT2 | GATM | ENSP00000231420 | ENSP00000379895 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | glycine amidinotransferase (L-arginine-glycine amidinotransferase); Catalyzes the biosynthesis of guanidinoacetate, the immediate precursor of creatine. Creatine plays a vital role in energy metabolism in muscle tissues. May play a role in embryonic and central nervous system development. May be involved in the response to heart failure by elevating local creatine synthesis | 0.918 |
AGXT2 | GCAT | ENSP00000231420 | ENSP00000371110 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | glycine C-acetyltransferase | 0.900 |
AGXT2 | GLDC | ENSP00000231420 | ENSP00000370737 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | glycine dehydrogenase (decarboxylating); The glycine cleavage system catalyzes the degradation of glycine. The P protein binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein | 0.953 |
AGXT2 | GNMT | ENSP00000231420 | ENSP00000361894 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | glycine N-methyltransferase; Catalyzes the methylation of glycine by using S- adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy). Possible crucial role in the regulation of tissue concentration of AdoMet and of metabolism of methionine | 0.909 |
AGXT2 | PIPOX | ENSP00000231420 | ENSP00000317721 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | pipecolic acid oxidase; Metabolizes sarcosine, L-pipecolic acid and L-proline | 0.904 |
AGXT2 | SARDH | ENSP00000231420 | ENSP00000360938 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | sarcosine dehydrogenase | 0.909 |
AGXT2 | SHMT1 | ENSP00000231420 | ENSP00000318868 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | serine hydroxymethyltransferase 1 (soluble); Interconversion of serine and glycine (By similarity) | 0.900 |
AGXT2 | SHMT2 | ENSP00000231420 | ENSP00000333667 | alanine--glyoxylate aminotransferase 2; Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure | serine hydroxymethyltransferase 2 (mitochondrial); Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Interconversion of serine and glycine. Associates with mitochondrial DNA | 0.913 |